NCT05951309View on ClinicalTrials.gov

Myoinositol Treatment and Asprosin Levels in PCOS

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

June 3, 2023

Conditions
PCOSInsulin Resistance
Interventions
DRUG

inofolic combi

The patients in this group were given inofolic combi once a day for 12-16 weeks

DRUG

Glucophage 500Mg Tablet

The patients in this group were given glucophage three times a day for 12-16 weeks

Trial Locations (1)

99138

Near East University Faculty of Medicine, Nicosia

All Listed Sponsors
lead

Near East University, Turkey

OTHER

NCT05951309 - Myoinositol Treatment and Asprosin Levels in PCOS | Biotech Hunter | Biotech Hunter